No CrossRef data available.
Article contents
Treatment resistant psicosis
Published online by Cambridge University Press: 16 April 2020
Abstract
Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
The aim is to charactherize the clinical data: psychopathologic state, pharmacological treatment and sociodemographical data; in a population of long-term institutionalized schizophrenic patients. Treatment resistant patients will be compared to non treatment resistant schizophrenics.
The target population is a convenience sample of our institutionalized patients. We chose a total of 60 schizophrenic patients, 100% women, diagnosed following the ICD-10 criteria. Specific survey was applied by the group of investigators: PANSS, Global Assessment Scale (GAS), and Clinical Global Impression (CGI).
Statistical analysis was performed with SPSS v 15.0, including descriptive statistics and correlation analysis.
Neuroleptic Polipharmacy is the most frequent tretment prescribed, just a 3,7% of the treatment resistant patients is on monotherapy. Despite polipharmacy, patients show a long term acute state.
- Type
- P03-279
- Information
- European Psychiatry , Volume 26 , Issue S2: Abstracts of the 19th European Congress of Psychiatry , March 2011 , pp. 1448
- Copyright
- Copyright © European Psychiatric Association 2011
You have
Access
Comments
No Comments have been published for this article.